Novel mechanism for obesity-induced colon cancer progression

Carcinogenesis

Volumn 30, Issue 4, 2009, Pages 690-697

  Birmingham, Janette M ^a   Busik, Julia V ^b   Hansen Smith, Fay M ^c   Fenton, Jenifer I ^a  

^a Michigan State University   (United States)

^b Oakland University ^*  (United States)

^c OAKLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEPTIN; NEUTRALIZING ANTIBODY; VASCULOTROPIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CANCER GROWTH; CELL ADHESION; CELL PROLIFERATION; CHEMOTAXIS; COLON CANCER; COLON CARCINOGENESIS; COLON POLYPOSIS; CONTROLLED STUDY; DNA BINDING; EPITHELIUM CELL; EX VIVO STUDY; GENE MUTATION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHEMOTAXIS; COLONIC NEOPLASMS; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LEPTIN; MALE; MESENTERY; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; NF-KAPPA B; OBESITY; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 64349089491     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp041     Document Type: Article

References (50)

1. Bianchini,F. et al. (2002) Overweight, obesity, and cancer risk. Lancet Oncol., 3, 565-574.
2. Calle,E.E. et al. (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4, 579-591.
3. Gunter,M.J. et al. (2006) Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. J. Nutr. Biochem., 17, 145-156.
4. Vendrell,J. et al. (2004) Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: Relationships in obesity. Obes. Res. 12, 962-971.
5. Stattin,P. et al. (2003) Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden. Oncol. Rep., 10, 2015-2021.
6. Saglam,K. et al. (2003) Leptin influences cellular differentiation and progression in prostate cancer. J. Urol., 169, 1308-1311.
7. Chen,D.C. et al. (2006) Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett., 237, 109-114.
8. Goktas,S. et al. (2005) Prostate cancer and adiponectin. Urology, 65, 1168-1172.
9. Attoub,S. et al. (2000) Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. FASEB J., 14, 2329-2338.
10. Hardwick,J.C. et al. (2001) Leptin is a growth factor for colonic epithelial cells. Gastroenterology, 121, 79-90.
11. Aparicio,T. et al. (2005) Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice or intestinal tumorigenesis in Apc(Min/+) mice. Gut, 54, 1136-1145.
12. Okumura,M. et al. (2002) Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: Reciprocal involvement of PKC-alpha and PPAR expression. Biochim. Biophys. Acta, 1592 107-116.
13. Somasundar,P. et al. (2003) Differential effects of leptin on cancer in vitro. J. Surg. Res., 113, 50-55.
14. Frankenberry,K.A. et al. (2004) Leptin induces cell migration and the expression of growth factors in human prostate cancer cells. Am. J. Surg., 188, 560-565.
15. Choi,J.H. et al. (2005) Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells. J. Clin. Endocrinol. Metab., 90, 207-210.
16. de Visser,K.E. et al. (2006) Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer, 6, 24-37.
17. Haramis,A.P. et al. (2006) Adenomatous polyposis coli-deficient zebrafish are susceptible to digestive tract neoplasia. EMBO Rep., 7, 444-449.
18. Mahmoud,N.N. et al. (1999) Genotype-phenotype correlation in murine Apc mutation: Differences in enterocyte migration and response to sulindac. Cancer Res., 59, 353-359.
19. Kagnoff,M.F. et al. (1997) Epithelial cells as sensors for microbial infection. J. Clin. Invest., 100, 6-10.
20. Hanahan,D. et al. (2000) The hallmarks of cancer. Cell, 100, 57-70.
21. Hicklin,D.J. et al. (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J. Clin. Oncol., 23, 1011-1027.
22. Reinmuth,N. et al. (2003) Biology of angiogenesis in tumors of the gastrointestinal tract. Microsc. Res. Tech., 60, 199-207.
23. O'Byrne,K.J. et al. (2000) The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. Eur. J. Cancer, 36, 151-169.
24. Hwang,J. et al. (2005) Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis. Cytokine, 30, 254-263.
25. Son,K.N. et al. (2006) Human CC chemokine CCL23 enhances expression of matrix metalloproteinase-2 and invasion of vascular endothelial cells. Biochem. Biophys. Res. Commun., 340, 498-504.
26. Fenton,J.I. et al. (2005) Leptin, insulin-like growth factor-1, and insulin-like growth factor-2 are mitogens in ApcMin/+ but not Apc+/+ colonic epithelial cell lines. Cancer Epidemiol. Biomarkers Prev., 14, 1646-1652.
27. Whitehead,R.H. et al. (1994) Derivation of conditionally immortalized cell lines containing the Min mutation from the normal colonic mucosa and other tissues of an "Immortomouse"/Min hybrid. Epithelial Cell Biol., 3, 119-125.
28. Mei,J.M. et al. (2000) Expression of prostaglandin endoperoxide H synthase-2 induced by nitric oxide in conditionally immortalized murine colonic epithelial cells. FASEB J., 14, 1188-1201.
29. Fenton,J.I. et al. (2002) Membrane-type matrix metalloproteinases mediate curcumin-induced cell migration in non-tumorigenic colon epithelial cells differing in Apc genotype. Carcinogenesis, 23 1065-1070.
30. Sierra-Honigmann,M.R. et al. (1998) Biological action of leptin as an angiogenic factor. Science, 281, 1683-1686.
31. Ronti,T. et al. (2006) The endocrine function of adipose tissue: an update. Clin. Endocrinol. (Oxf), 64, 355-365.
32. Fenton,J.I. et al. (2006) Stage matters: Choosing relevant model systems to address hypotheses in diet and cancer chemoprevention research. Carcinogenesis, 27, 893-902.
33. Ahren,B. (1999) Plasma leptin and insulin in C57BI/6J mice on a high-fat diet: Relation to subsequent changes in body weight. Acta Physiol. Scand., 165, 233-240.
34. Considine,R.V. et al. (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334, 292-295.
35. Bessho,R. et al. (1994) Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes. Biochem. Pharmacol., 48, 1883-1889.
36. Hansen-Smith,F.M. et al. (1994) Regional differences in spontaneously occurring angiogenesis in the adult rat mesentery. Microvasc. Res., 47, 369-376.
37. Hansen-Smith,F.M. (2000) Capillary network patterning during angiogenesis. Clin. Exp. Pharmacol. Physiol., 27, 830-835.
38. Hord,N.G. et al. (1994) Physicochemical and immunocytochemical analysis of the aryl hydrocarbon receptor nuclear translocator: characterization of two monoclonal antibodies to the aryl hydrocarbon receptor nuclear translocator. Mol. Pharmacol., 46, 618-626.
39. Fenton,J.I. et al. (2006) Interleukin-6 production induced by leptin treatment promotes cell proliferation in an Apc (Min/+) colon epithelial cell line. Carcinogenesis, 27, 1507-1515.
40. Kim,I. et al. (2001) Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J. Biol. Chem., 276, 7614-7620.
41. Mukhopadhyay,D. et al. (2004) Complexity in the vascular permeability factor/vascular endothelial growth factor (VPF/ VEGF)-receptors signaling. Mol. Cell. Biochem., 264, 51-61.
42. Fan,F. et al. (2005) Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells. Oncogene, 24, 2647-2653.
43. Su,J.L. et al. (2006) The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell, 9, 209-223.
44. von Marschall,Z. et al. (2000) De novo expression of vascular endothelial growth factor in human pancreatic cancer: Evidence for an autocrine mitogenic loop. Gastroenterology, 119, 1358-1372.
45. Ferrara,N. et al. (2003) The biology of VEGF and its receptors. Nat. Med., 9, 669-676.
46. Cebe-Suarez,S. et al. (2006) The role of VEGF receptors in angiogenesis; complex partnerships. Cell. Mol. Life Sci., 63 601-615.
47. Gallicchio,M. et al. (2008) Celecoxib decreases expression of the adhesion molecules ICAM-1 and VCAM-1 in a colon cancer cell line (HT29). Br. J. Pharmacol., 153, 870-878.
48. Korsisaari,N. et al. (2007) Inhibition of VEGF-A prevents the angiogenic switch and results in increased survival of Apc+/min mice. Proc. Natl Acad. Sci. USA, 104, 10625-10630.
49. Goodlad,R.A. et al. (2006) Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer. Carcinogenesis, 27, 2133-2139.
50. Mai,V. et al. (2003) Calorie restriction and diet composition modulate spontaneous intestinal tumorigenesis in Apc(Min) mice through different mechanisms. Cancer Res., 63, 1752-1755.